Search - tctmd.com

Displaying 1 - 20 of 54

Sort: Relevancy | Date

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

March 30, 2026

Redo-SURgery vs Transcatheter Valve-In-Valve for Mitral Bioprosthetic Dysfunction: The SURVIV Trial

Presentation ACC 2026

Redo-SURgery vs Transcatheter Valve-In-Valve for Mitral Bioprosthetic Dysfunction: The SURVIV Trial

Presenter: Dimytri Siqueira

March 29, 2026

What’s Going to Be Hot at ACC 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

What’s Going to Be Hot at TCT 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

News Daily News

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

July 31, 2025

Presentation Miami Valves 2025

A Case of Severe Bioprosthetic Valve Dysfunction

Presenter: Som Bailey

January 30, 2025

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

Trans-Septal Mitral Valve-in-Valve Procedure for Severe Bioprosthetic Mitral Valve Stenosis

Presentation Miami Valves 2024

Trans-Septal Mitral Valve-in-Valve Procedure for Severe Bioprosthetic Mitral Valve Stenosis

Presenter: Nicholas J. Ruggiero II

February 03, 2024

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

May 19, 2023

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

November 21, 2022

Failed Mitral Surgical Bioprosthetic Valve & PVL

Presentation Miami Valves 2022

Failed Mitral Surgical Bioprosthetic Valve & PVL

Presenter: Fábio S. de Brito Jr.,

February 04, 2022

Cardiogenic shock in the setting of bioprosthetic mitral valve failure

Presentation Miami Valves 2022

Cardiogenic shock in the setting of bioprosthetic mitral valve failure

Presenter: Hamza Ali Lodhi

February 03, 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

News Conference News STS 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

February 02, 2022

July/August 2021 News Roundup

News Opinion CV Team Dispatch

July/August 2021 News Roundup

August 01, 2021

DOACs Safe, Effective in Subset of Valvular AF Patients

News Daily News

DOACs Safe, Effective in Subset of Valvular AF Patients

March 31, 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

March 08, 2021

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

December 23, 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

November 14, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.